Works matching AU Wang, Mengzhao
Results: 155
Perioperative Treatment in EGFR‐Mutant Early‐Stage Non‐Small Cell Lung Cancer: Current Evidence and Future Perspectives.
- Published in:
- Thoracic Cancer, 2025, v. 16, n. 4, p. 1, doi. 10.1111/1759-7714.70018
- By:
- Publication type:
- Article
Dynamic gut microbiota changes in patients with advanced malignancies experiencing secondary resistance to immune checkpoint inhibitors and immune-related adverse events.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1144534
- By:
- Publication type:
- Article
Peripheral Blood Lymphocyte Subsets Predict the Efficacy of Immune Checkpoint Inhibitors in Non--Small Cell Lung Cancer.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.912180
- By:
- Publication type:
- Article
Immune responses and reinfection of SARS‐CoV‐2 Omicron variant in patients with lung cancer.
- Published in:
- International Journal of Cancer, 2024, v. 155, n. 8, p. 1409, doi. 10.1002/ijc.35038
- By:
- Publication type:
- Article
Chromium Induces Toxicity at Different Phenotypic, Physiological, Biochemical, and Ultrastructural Levels in Sweet Potato (Ipomoea batatas L.) Plants.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 21, p. 13496, doi. 10.3390/ijms232113496
- By:
- Publication type:
- Article
Genome reannotation of the sweetpotato (Ipomoea batatas (L.) Lam.) using extensive Nanopore and Illumina-based RNA-seq datasets.
- Published in:
- Tropical Plants, 2024, v. 3, n. 1, p. 1, doi. 10.48130/tp-0024-0009
- By:
- Publication type:
- Article
The Clinical Analysis of Checkpoint Inhibitor Pneumonitis with Different Severities in Lung Cancer Patients: A Retrospective Study.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 1, p. 255, doi. 10.3390/jcm13010255
- By:
- Publication type:
- Article
Associations of modifiable dementia risk factors with dementia and cognitive decline: evidence from three prospective cohorts.
- Published in:
- Frontiers in Public Health, 2025, p. 1, doi. 10.3389/fpubh.2025.1529969
- By:
- Publication type:
- Article
Elevated levels of pre-treatment lactate dehydrogenase are an unfavorable predictor factor in patients with EML4-ALK rearrangement non-small cell lung cancer treated with crizotinib.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 8191, doi. 10.2147/CMAR.S213572
- By:
- Publication type:
- Article
Esophagus-like Bronchus in an Adult with Common Variable Immunodeficiency Disease.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The association between ROS1 rearrangement and risk of thromboembolic events in patients with advanced non-small cell lung cancer: a multicenter study in China.
- Published in:
- Thrombosis Journal, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12959-022-00417-8
- By:
- Publication type:
- Article
Bronchoalveolar lavage fluid analysis in patients with checkpoint inhibitor pneumonitis.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03834-y
- By:
- Publication type:
- Article
Effects of aerobic exercises in prediabetes patients: a systematic review and meta-analysis.
- Published in:
- Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1227489
- By:
- Publication type:
- Article
Leptomeningeal enhancement in magnetic resonance imaging predicts poor prognosis in lung adenocarcinoma patients with leptomeningeal metastasis.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 7, p. 1059, doi. 10.1111/1759-7714.14362
- By:
- Publication type:
- Article
Clinical characteristics and prognostic model for extensive-stage small cell lung cancer: A retrospective study over an 8-year period.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 4, p. 539, doi. 10.1111/1759-7714.14289
- By:
- Publication type:
- Article
Circulating cytokines associated with clinical outcomes in advanced non‐small cell lung cancer patients who received chemoimmunotherapy.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 2, p. 219, doi. 10.1111/1759-7714.14248
- By:
- Publication type:
- Article
Value and significance of brain radiation therapy during first‐line EGFR‐TKI treatment in lung adenocarcinoma with EGFR sensitive mutation and synchronous brain metastasis: Appropriate timing and technique.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 23, p. 3157, doi. 10.1111/1759-7714.14169
- By:
- Publication type:
- Article
Study protocol: A single‐arm, multicenter, phase II trial of camrelizumab plus apatinib for advanced nonsquamous NSCLC previously treated with first‐line immunotherapy.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 20, p. 2825, doi. 10.1111/1759-7714.14113
- By:
- Publication type:
- Article
Feasibility and reliability of evaluate PD‐L1 expression determination using small biopsy specimens in non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 17, p. 2339, doi. 10.1111/1759-7714.14075
- By:
- Publication type:
- Article
Prognostic impact of maximum standardized uptake value on <sup>18</sup>F‐FDG PET/CT imaging of the primary lung lesion on survival in advanced non‐small cell lung cancer: A retrospective study.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 6, p. 845, doi. 10.1111/1759-7714.13863
- By:
- Publication type:
- Article
Genomic characteristics of driver genes in Chinese patients with non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 3, p. 357, doi. 10.1111/1759-7714.13757
- By:
- Publication type:
- Article
Recommendations and exploration of diagnosis and treatment of critical and refractory immune checkpoint inhibitor‐associated adverse events.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 8, p. 2077, doi. 10.1111/1759-7714.13553
- By:
- Publication type:
- Article
Successful treatment of pulmonary inflammatory myofibroblastic tumor with platinum‐pemetrexed: The first report of two cases.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 8, p. 2339, doi. 10.1111/1759-7714.13520
- By:
- Publication type:
- Article
Clinical recommendations on lung cancer management during the COVID‐19 pandemic.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 7, p. 2067, doi. 10.1111/1759-7714.13498
- By:
- Publication type:
- Article
Immunotherapy as second‐line treatment and beyond for non‐small cell lung cancer in a single center of China: Outcomes, toxicities, and clinical predictive factors from a real‐world retrospective analysis.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 7, p. 1955, doi. 10.1111/1759-7714.13488
- By:
- Publication type:
- Article
Treatment with or without bevacizumab as a first‐line and maintenance therapy for advanced non‐squamous non‐small cell lung cancer: A retrospective study.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 7, p. 1869, doi. 10.1111/1759-7714.13469
- By:
- Publication type:
- Article
Opportunistic infections complicating immunotherapy for non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 6, p. 1689, doi. 10.1111/1759-7714.13422
- By:
- Publication type:
- Article
Patterns of response in metastatic NSCLC during PD‐1 or PD‐L1 inhibitor therapy: Comparison of the RECIST 1.1 and iRECIST criteria.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 4, p. 1068, doi. 10.1111/1759-7714.13367
- By:
- Publication type:
- Article
Clinical diagnosis and treatment recommendations for ocular toxicities of targeted therapy and immune checkpoint inhibitor therapy.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 3, p. 810, doi. 10.1111/1759-7714.13327
- By:
- Publication type:
- Article
Management of immune checkpoint inhibitor‐related adverse events: A review of case reports.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 3, p. 498, doi. 10.1111/1759-7714.13315
- By:
- Publication type:
- Article
Histologic transformation of lung cancer during pembrolizumab therapy: A case report.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 3, p. 793, doi. 10.1111/1759-7714.13312
- By:
- Publication type:
- Article
Abivertinib in patients with T790M‐positive advanced NSCLC and its subsequent treatment with osimertinib.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 3, p. 594, doi. 10.1111/1759-7714.13302
- By:
- Publication type:
- Article
Management of immune checkpoint inhibitor‐related dermatologic adverse events.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 2, p. 488, doi. 10.1111/1759-7714.13275
- By:
- Publication type:
- Article
Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated pneumonitis.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 1, p. 191, doi. 10.1111/1759-7714.13240
- By:
- Publication type:
- Article
Clinical features and outcomes of ALK rearranged non‐small cell lung cancer with primary resistance to crizotinib.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 5, p. 1213, doi. 10.1111/1759-7714.13071
- By:
- Publication type:
- Article
Thymic neoplasms patients complicated with bronchiectasis: Case series in a Chinese hospital and literature review.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 4, p. 791, doi. 10.1111/1759-7714.13000
- By:
- Publication type:
- Article
Management of anlotinib‐related adverse events in patients with advanced non‐small cell lung cancer: Experiences in ALTER‐0303.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 3, p. 551, doi. 10.1111/1759-7714.12977
- By:
- Publication type:
- Article
Afatinib as first‐line treatment for advanced lung adenocarcinoma patients harboring HER2 mutation: A case report and review of the literature.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 12, p. 1788, doi. 10.1111/1759-7714.12906
- By:
- Publication type:
- Article
Establishment of a prospective multicenter cohort for advanced non‐small cell lung cancer in China (CAPTRA‐Lung study).
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 12, p. 1795, doi. 10.1111/1759-7714.12865
- By:
- Publication type:
- Article
Nimotuzumab combined with chemotherapy as first‐line treatment for advanced lung squamous cell carcinoma.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 8, p. 1056, doi. 10.1111/1759-7714.12789
- By:
- Publication type:
- Article
ALK‐rearranged lung cancer with intradural extramedullary spinal cord metastases responding to ceritinib treatment: A case report.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 8, p. 1078, doi. 10.1111/1759-7714.12778
- By:
- Publication type:
- Article
Prognostic role of circulating tumor cells in patients with <italic>EGFR</italic>‐mutated or <italic>ALK</italic>‐rearranged non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 5, p. 640, doi. 10.1111/1759-7714.12631
- By:
- Publication type:
- Article
Pharmacokinetic analysis of gefitinib in a patient with advanced non-small cell lung cancer undergoing hemodialysis.
- Published in:
- Thoracic Cancer, 2016, v. 7, n. 2, p. 251, doi. 10.1111/1759-7714.12263
- By:
- Publication type:
- Article
Efficacy of bronchoscopic biopsy for the detection of epidermal growth factor receptor mutations and anaplastic lymphoma kinase gene rearrangement in lung adenocarcinoma.
- Published in:
- Thoracic Cancer, 2015, v. 6, n. 6, p. 709, doi. 10.1111/1759-7714.12245
- By:
- Publication type:
- Article
The Prevalence and clinical characteristics of primary Sjogren's syndrome patients with lung cancer: An analysis of ten cases in China and literature review.
- Published in:
- Thoracic Cancer, 2015, v. 6, n. 4, p. 475, doi. 10.1111/1759-7714.12216
- By:
- Publication type:
- Article
Current small cell lung cancer treatment in China.
- Published in:
- Thoracic Cancer, 2015, v. 6, n. 3, p. 233, doi. 10.1111/1759-7714.12218
- By:
- Publication type:
- Article
Clinical characteristics of patients with lung cancer and idiopathic pulmonary fibrosis in China.
- Published in:
- Thoracic Cancer, 2012, v. 3, n. 2, p. 156, doi. 10.1111/j.1759-7714.2012.00108.x
- By:
- Publication type:
- Article
Renal immune‐related adverse events of immune checkpoint inhibitor.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2020, v. 16, n. 6, p. 305, doi. 10.1111/ajco.13387
- By:
- Publication type:
- Article
Programmed cell death 1 (PD‐1)/PD‐ligand 1(PD‐L1) inhibitors‐related pneumonitis in patients with advanced non–small cell lung cancer.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2020, v. 16, n. 6, p. 299, doi. 10.1111/ajco.13380
- By:
- Publication type:
- Article
The role of immunosuppressive agents in the management of severe and refractory immune‐related adverse events.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2020, v. 16, n. 4, p. 201, doi. 10.1111/ajco.13332
- By:
- Publication type:
- Article